October 26, 2020
2 min watch
Save
Greatest areas of unmet need in anti-VEGF treatment for retinal vascular diseases
Healio spoke with Rishi P. Singh, MD, staff surgeon at Cleveland Clinic Cole Eye Institute, associate professor of ophthalmology at Lerner College of Medicine and Healio/OSN Board Member, about greatest areas of unmet need in anti-VEGF treatment for neovascular AMD and other retinal vascular diseases, including a need to better monitor patients remotely to get a longitudinal view of what’s happening with patients and the need for durable treatment options, and the need for more insight into prognostication.
Click here to watch more from the Anti-VEGF Video Perspectives video series.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Singh reports consulting for Alcon, Bausch + Lomb, Genentech, Novartis, Regeneron and Zeiss, and research grants from Aerie Pharmaceuticals, Apellis and Graybug.